The Advanced Research Projects Agency for Health (ARPA-H) has named Atman Health among the teams receiving contract awards under its Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program. The announcement, made on September 9, 2026, positions Atman Health to build a patient-facing clinical AI agent designed for heart failure patients.
Contract Award Details
Atman Health’s award record lists a contract of up to $7.7 million. The company confirmed its selection the same day, stating that it will develop an agentic artificial intelligence solution as part of the ARPA-H initiative.
About the ADVOCATE Program
The ADVOCATE program, led by ARPA-H, focuses on transforming cardiovascular care through agentic AI technologies. Atman Health is one of the performers selected to contribute to this effort, specifically tasked with creating a voice-first AI agent for heart failure patients.
